dalteparin has been researched along with Female Genital Diseases in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Excerpt | Relevance | Reference |
---|---|---|
"No deep venous thrombosis and no pulmonary embolism were observed." | 1.29 | [General perioperative prevention of thromboembolism in gynecology with low-molecular weight heparin: clinical experiences with enoxaparin over 7 years]. ( Slunsky, R, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Slunsky, R | 1 |
Ward, B | 1 |
Pradhan, S | 1 |
1 trial available for dalteparin and Female Genital Diseases
Article | Year |
---|---|
Comparison of low molecular weight heparin (Fragmin) with sodium heparin for prophylaxis against postoperative thrombosis in women undergoing major gynaecological surgery.
Topics: Anticoagulants; Dalteparin; Female; Genital Diseases, Female; Heparin; Humans; Injections, Subcutane | 1998 |
1 other study available for dalteparin and Female Genital Diseases
Article | Year |
---|---|
[General perioperative prevention of thromboembolism in gynecology with low-molecular weight heparin: clinical experiences with enoxaparin over 7 years].
Topics: Adult; Aged; Anticoagulants; Blood Coagulation Tests; Combined Modality Therapy; Dose-Response Relat | 1995 |